Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes

Basista Rabina Sharma; Swarna Jaiswal; P. V. Ravindra

doi:10.1016/j.biopha.2022.113148

Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes

Basista Rabina Sharma
, Swarna Jaiswal
, P. V. Ravindra

Research output: Contribution to journal › Review article › peer-review

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia and insulin resistance. Gut microbiota (GM) are specific groups of microbes colonized in the gastrointestinal (GI) tract. They profoundly influence health, disease protection, and associated with metabolic activities, and play a vital role in the production of functional metabolites from dietary substances. Dysbiosis of GM has been linked to the onset of T2DM and can be altered to attain eubiosis by intervention with various nutritional bioactive compounds such as polyphenols, prebiotics, and probiotics. This review presents an overview of the evidence and underlying mechanisms by which bioactive compounds modulate the GM for the prevention and management of T2DM.

Original language	English
Article number	113148
Journal	Biomedicine and Pharmacotherapy
Volume	152
DOIs	https://doi.org/10.1016/j.biopha.2022.113148
Publication status	Published - Aug 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Dysbiosis
Eubiosis
Gut microbiota
Type 2 diabetes

Access to Document

10.1016/j.biopha.2022.113148Licence: CC BY-NC-ND

https://arrow.tudublin.ie/schfsehart/513Licence: CC BY-NC-ND

Cite this

@article{00b1737932e44cd48c34aee9e38787a9,

title = "Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes",

abstract = "Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia and insulin resistance. Gut microbiota (GM) are specific groups of microbes colonized in the gastrointestinal (GI) tract. They profoundly influence health, disease protection, and associated with metabolic activities, and play a vital role in the production of functional metabolites from dietary substances. Dysbiosis of GM has been linked to the onset of T2DM and can be altered to attain eubiosis by intervention with various nutritional bioactive compounds such as polyphenols, prebiotics, and probiotics. This review presents an overview of the evidence and underlying mechanisms by which bioactive compounds modulate the GM for the prevention and management of T2DM.",

keywords = "Dysbiosis, Eubiosis, Gut microbiota, Type 2 diabetes",

author = "Sharma, \{Basista Rabina\} and Swarna Jaiswal and Ravindra, \{P. V.\}",

note = "Publisher Copyright: {\textcopyright} 2022",

year = "2022",

month = aug,

doi = "10.1016/j.biopha.2022.113148",

language = "English",

volume = "152",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier Masson s.r.l.",

}

TY - JOUR

T1 - Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes

AU - Sharma, Basista Rabina

AU - Jaiswal, Swarna

AU - Ravindra, P. V.

PY - 2022/8

Y1 - 2022/8

N2 - Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia and insulin resistance. Gut microbiota (GM) are specific groups of microbes colonized in the gastrointestinal (GI) tract. They profoundly influence health, disease protection, and associated with metabolic activities, and play a vital role in the production of functional metabolites from dietary substances. Dysbiosis of GM has been linked to the onset of T2DM and can be altered to attain eubiosis by intervention with various nutritional bioactive compounds such as polyphenols, prebiotics, and probiotics. This review presents an overview of the evidence and underlying mechanisms by which bioactive compounds modulate the GM for the prevention and management of T2DM.

AB - Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia and insulin resistance. Gut microbiota (GM) are specific groups of microbes colonized in the gastrointestinal (GI) tract. They profoundly influence health, disease protection, and associated with metabolic activities, and play a vital role in the production of functional metabolites from dietary substances. Dysbiosis of GM has been linked to the onset of T2DM and can be altered to attain eubiosis by intervention with various nutritional bioactive compounds such as polyphenols, prebiotics, and probiotics. This review presents an overview of the evidence and underlying mechanisms by which bioactive compounds modulate the GM for the prevention and management of T2DM.

KW - Dysbiosis

KW - Eubiosis

KW - Gut microbiota

KW - Type 2 diabetes

UR - https://www.scopus.com/pages/publications/85131442747

U2 - 10.1016/j.biopha.2022.113148

DO - 10.1016/j.biopha.2022.113148

M3 - Review article

C2 - 35665671

AN - SCOPUS:85131442747

SN - 0753-3322

VL - 152

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

M1 - 113148

ER -

Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes

Abstract

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this